Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/47456
Title: LC-MS/MS proteomics analysis of biomarkers in Singapore breast cancer patients on doxorubicin treatment and MCF7 breast cancer derived cells
Authors: Bahareh Haji Rasouliha
Keywords: DRNTU::Engineering::Chemical engineering::Biotechnology
Issue Date: 2010
Source: Bahareh, H. R. (2010). LC-MS/MS proteomics analysis of biomarkers in Singapore breast cancer patients on doxorubicin treatment and MCF7 breast cancer derived cells. Master’s thesis, Nanyang Technological University, Singapore.
Abstract: Breast cancer is known as the most common cancer in women population, especially in developed countries. Improved prognosis and effective treatment are needed to reduce the mortality of the disease. Doxorubicin, a topoisomerase II-targeting chemotherapeutic drug has been widely used to treat breast cancer. The rapidly evolved proteomics techniques, especially LC-MS/MS analysis, has been used in protein profiling in body fluids as well as cells, which provide us with a deep comprehension in drugs mechanism and patients response to the treatment. This new method can be extended in biomarker identification to improve diagnosis and monitoring of treatment.
Description: 97 p.
URI: http://hdl.handle.net/10356/47456
Rights: Nanyang Technological University
metadata.item.grantfulltext: restricted
metadata.item.fulltext: With Fulltext
Appears in Collections:SCBE Theses

Files in This Item:
File Description SizeFormat 
SCBE_THESES_1.pdf9.83 MBAdobe PDFThumbnail
View/Open

Page view(s)

407
checked on Dec 20, 2019

Download(s)

394
checked on Dec 20, 2019

Google ScholarTM

Check

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.